Kite Appoints Frank Neumann as Worldwide Head of Clinical Development
Go back to Kite Appoints Frank Neumann as Worldwide Head of Clinical Development| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.60 -0.27 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.87 | 52 Week High | $108.63 | |||
| Open | $126.13 | 52 Week Low | $71.39 | |||
| Day High | $126.51 | P/E | 69.39 | |||
| Day Low | $124.29 | EPS | $1.81 | |||
| Volume | 3,935,828 | |||||

